Facebook Instagram Linkedin Youtube
Home Tags Cancer immunotherapy

Tag: cancer immunotherapy

BioInvent immunotherapy 2.0

Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0”

Alligator to maximise immuno-oncology innovation

Alligator to maximise immuno-oncology innovation

Alligators vd om den aktuella utvecklingen och företrädesemissionen

Alligator’s CEO on current development and the rights issue

Annexin 2024 start

Strong start for Annexin in 2024

Carlos de Sousa, CEO Ultimovacs

Ultimovacs CEO: “Data could put us at the forefront of cancer...

Alligator orphan designation EMA

Alligator Bioscience expands orphan designation to Europe

Alligator CD40 durable

Phase II results indicate durability of response for Alligator’s CD40 agonist

Elicera uppdaterar i samband med Cancer Immunotherapy Month

Elicera gives an update in Cancer Immunotherapy Month

Janssen CAR T deal supports Elicera’s vision

Janssen CAR T deal supports Elicera’s vision

Medivir’s CEO: “The IND approval is a very important milestone”

Alligator gearing up for new milestones with mitazalimab

12Page 1 of 2
© BioStock 2025